Conray 30 (Liebel-Flarsheim Company LLC)


Welcome to the PulseAid listing for the Conray 30 drug offered from Liebel-Flarsheim Company LLC. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Liebel-Flarsheim Company LLC
NON-PROPRIETARY NAME: Iothalamate Meglumine
SUBSTANCE NAME: IOTHALAMATE MEGLUMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: INTRAVASCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-03-26
END MARKETING DATE: 0000-00-00


Conray 30 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionConray 30 from Liebel-Flarsheim Company LLC
LABELER NAME: Liebel-Flarsheim Company LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/mL)
START MARKETING DATE: 2012-03-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0019-0952_e80407fa-3e59-461f-a0ab-c30384294c58
PRODUCT NDC: 0019-0952
APPLICATION NUMBER: NDA016983

Other IOTHALAMATE MEGLUMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Liebel-Flarsheim Company LLCCysto-Conray II